Thermo Fisher Scientific and Flagship Pioneering are forming a partnership to create companies that make biotechnology tools. The partnership will match Flagship’s venture formation expertise and ...
PARISH, N.Y. — APW High School has partnered with local biotech company BioSpherix to enhance students' STEM education through the donation of an advanced Xvivo System. This unique glovebox incubator ...
As healthcare technology accelerates across the globe, students are increasingly drawn to two interdisciplinary fields at the cutting edge of innovation: biotechnology and biomedical engineering. Both ...
The ability of scientists to rationally engineer organisms using synthetic biology, or “engineering biology” as I prefer to call it, has progressed greatly since high throughput molecular biology ...
Future research aims to enhance TALEN's efficiency and specificity, potentially combining it with CRISPR or base editing technologies for advanced genetic engineering applications. Despite its ...
This Collection supports and amplifies research related to SDG 2, SDG 3 and SDG 9. Plant biotechnology is undergoing a transformative era, driven by rapid advancements in molecular biology, genetic ...
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gen ...
New Rochelle, NY, August 6, 2012—Genetic Engineering & Biotechnology News (http://www.genengnews.com) (GEN) has launched a unique microsite called Biotech Boulevard ...
On October 2, 2024, the U.S. Environmental Protection Agency (EPA), U.S. Food and Drug Administration (FDA), and U.S. Department of Agriculture (USDA) announced the release of a new web-based tool on ...
Aaron Love (MBP ’13) had a passion for biology and improving human health when he arrived at Northwestern Engineering's Master of Biotechnology Program (MBP). Today he's pursuing those passions as a ...
Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting market ...